Full Press Release Details
argenx to Report Full Year 2022 Financial Results and Fourth Quarter Business Update on March 2, 2023.
ARGX
argenx to Report Full Year 2022 Financial Results and Fourth Quarter Business Update on March 2, 2023
Key Takeaway: argenx to Report Full Year 2022 Financial Results and Fourth Quarter Business Update on March 2, 2023
Price reaction · baseline $367.72 (2023-02-23 close) · hit after-hours · 3 other ARGX headline(s) in the window, move may be shared
day 0 close
-0.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis